-
Latest News
- Characterization of post–exertional malaise in patients with ME/CFS
- An analysis of 2‐day cardiopulmonary exercise testing to assess unexplained fatigue
- Online talk: ME/CFS and long Covid in children & young people with Dr Nigel Speight, 24 Sep 2020
- Mitochondria & immunity in CFS
- Postviral fatigue syndrome and creatine: a piece of the puzzle?
Archives
Tag Archives: pharmacogenomics
Treatment avenues in ME/CFS: a split-gender pharmacogenomic study of gene-expression
Treatment avenues in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: a split-gender pharmacogenomic study of gene-expression modules, by Mary G Jeffrey, Lubov Nathanson, Kristina Aenlle, Zachary M Barnes, Mirza Baig, Gordon Broderick, Nancy G Klimas, Mary Ann Fletcher, Travis JA Craddock in Clinical … Continue reading →
Posted in News
|
Tagged bioinformatics, Dr Nancy Klimas, drug repositioning, Gordon Broderick, immune dysregulation, immunosuppressants, Kistina Aenlle, Lubov Nathanson, Mary Ann Fletcher, Mary G Jeffrey, Mirza Baig, pharmacogenomics, Travis JA Craddock, treatments, Zachary Barnes
|
Comments Off on Treatment avenues in ME/CFS: a split-gender pharmacogenomic study of gene-expression
